Patient Enrollment Completed for Clinical Trial of Peijia Medical’s Shenyi® Stent Retriever


Patient Enrollment Completed for Clinical Trial of Peijia Medical’s Shenyi® Stent Retriever

 

On February 1, 2021, Peijia Medical announced that patient enrollment for clinical trial of Shenyi® Stent Retriever had been successfully completed as of January 29, 2021. Shenyi® Stent Retriever is a major product under development from the Company’s neurointerventional product line.

Shenyi® Stent Retriever is used for removing fresh thrombus in intracranial vessels in a mechanical thrombectomy procedure for patients with acute ischemic stroke. As soon as all the preparations have been made, the Company plans to submit a registration application to National Medical Products Administration (NMPA).

 

For more information, please visit our WeChat Official Account:

https://mp.weixin.qq.com/s/vsMFNjXWOY4_u8eehEOXNQ

Patient Enrollment Completed for Clinical Trial of Peijia Medical’s Shenyi® Stent Retriever

 

On February 1, 2021, Peijia Medical announced that patient enrollment for clinical trial of Shenyi® Stent Retriever had been successfully completed as of January 29, 2021. Shenyi® Stent Retriever is a major product under development from the Company’s neurointerventional product line.

Shenyi® Stent Retriever is used for removing fresh thrombus in intracranial vessels in a mechanical thrombectomy procedure for patients with acute ischemic stroke. As soon as all the preparations have been made, the Company plans to submit a registration application to National Medical Products Administration (NMPA).

 

For more information, please visit our WeChat Official Account:

https://mp.weixin.qq.com/s/vsMFNjXWOY4_u8eehEOXNQ